Pfizer

Stories 41 - 60 | << Prev   Next >>

Pfizer Asks FDA to Authorize COVID Vaccine for Young Kids

Decision expected between Halloween and Thanksgiving

(Newser) - Pfizer and BioNTech formally requested that the FDA authorize emergency use of a coronavirus vaccine for more than 28 million US children aged 5 to 11 on Thursday, keeping in line with a plan to have the doses available by Thanksgiving . The FDA will now gather its vaccines advisory committee...

Pfizer's Protection Against COVID Infection Drops Sharply

Though it continues to be effective at preventing hospitalizations

(Newser) - A new large-scale study finds the protection against COVID-19 infection offered by the Pfizer-BioNTech vaccine drops from 88% in the first month to 47% after five months. The Los Angeles Times reports on what it describes as "one of the largest and longest [studies] to track the effectiveness of...

Pfizer Shot for Kids May Not Be Here Until November

Drugmaker has submitted data to FDA

(Newser) - Pfizer has submitted research to the Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children, but the shots may not be available until November. The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11...

Scientists: COVID Pill May Be Right Around the Corner

At least 3 promising antiviral drugs used to treat the disease in early stages are in clinical trials

(Newser) - We've got the vaccine. Next up: the pill? That's what scientists are crossing their fingers on regarding COVID treatment, with at least three antiviral drugs in clinical trials that have the potential to be a "game changer," keeping the worst symptoms at bay in infected patients...

Biden Will Get His Booster Shot Monday
Biden Gets His
COVID Booster Shot
UPDATED
Sep 27, 2021 2:10 PM CDT

Biden Gets His COVID Booster Shot

'It’s hard to acknowledge I’m over 65,' he jokes

(Newser) - President Biden received his COVID-19 booster shot on Monday, days after federal regulators recommended a third dose of the Pfizer vaccine for Americans age 65 or older and approved them for others with preexisting medical conditions and high-risk work environments. "The most important thing we need to do is...

FDA Adds Its Approval to Booster Shots for Seniors

The third Pfizer dose ideally would be given six months after the second one

(Newser) - Update: Coronavirus booster shots for people 65 and older and adults otherwise vulnerable to severe illness received the Food and Drug Administration's approval on Wednesday. The agency decided that anyone in a high-risk situation, possibly because of their job, also should be able to get a Pfizer booster, the...

Biden to Back Ambitious Global Vaccination Goal

Administration to commit to donate 1.1B doses through 2022

(Newser) - President Biden is set to announce that the US is doubling its purchase of Pfizer's COVID-19 shots to share with the world to 1 billion doses as he embraces the goal of vaccinating 70% of the global population within the next year, per the AP . The stepped-up commitment is...

Kids 5 to 11 May Get COVID Shots by Halloween

Pfizer reports lower dose appears safe and effective, to be reviewed by FDA

(Newser) - It looks like children ages 5 to 11 in US may be able to receive a COVID vaccination by Halloween. Pfizer on Monday reported that its vaccine appears to be safe and effective at a lower dose for children, reports the Washington Post . The company and partner BioNTech will submit...

US Plan for Booster Shots Hits a Roadblock

Federal authorities say it may be limited at first only to certain Pfizer recipients

(Newser) - Last month, the White House pushed a plan to start doling out COVID booster shots in September. The new message surfacing: Not so fast. The New York Times reports that the proposal to start administering the extra shots on September 20 will be dramatically scaled back. At best, only people...

Vaccine Name &#39;Comirnaty&#39; Is Not Going Over Well
Vaccine Name 'Comirnaty'
Is Not Going Over Well
THE RUNDOWN
Aug 24, 2021 6:59 AM CDT

Vaccine Name 'Comirnaty' Is Not Going Over Well

Still planning to call it the 'Pfizer vaccine'? You're not alone

(Newser) - Pfizer's COVID-19 vaccine may have gotten full FDA approval Monday, but the reaction wasn't all good: Many were scratching their heads over the new name it will be marketed under, Comirnaty. "The person(s) who came up with this name should never be allowed to name anything ever...

BioNTech, Pfizer Stocks Jump After FDA Approval
BioNTech, Pfizer Stocks
Jump After FDA Approval
MARKETS
Aug 23, 2021 4:03 PM CDT

BioNTech, Pfizer Stocks Jump After FDA Approval

Nasdaq hits new record high

(Newser) - Stocks closed higher on Wall Street Monday, allowing the S&P 500 to regain the ground it lost last week and bringing it just shy of another record high. The benchmark index added 0.9%, driven by gains in a broad range of technology, financial, and communication stocks. The tech-heavy...

Pfizer Vaccine Will Now Be Marketed Under a New Name

After winning full FDA approval, company can now sell it as Comirnaty

(Newser) - It's a big development on the COVID vaccine front: The FDA on Monday gave full approval to the Pfizer shots, reports the AP . The vaccine had previously been granted an emergency-use waiver, and winning full approval—it's the first vaccine to do so—could have wide-ranging implications.
  • New
...

There's Been a Date Shift for FDA's Full OK on Pfizer Vax

Labor Day was the initial target. Sources now say full approval could come as soon as Monday.

(Newser) - Earlier this month, the Food and Drug Administration signaled that it hoped to offer full approval for Pfizer-BioNTech's coronavirus vaccine by Labor Day, an unofficial deadline that now looks like it's been expedited. A senior federal official tells CNN that such an FDA OK is "imminent,"...

Pfizer Data: Booster Shot Provides an Actual Boost

Company data shows it increases protection against delta variant

(Newser) - For protection against the delta variant, new data from Pfizer suggests three doses are the way to go. In slides published ahead of a Wednesday earnings call, the company said that antibody levels against the delta variant were five times higher in the 18-to-55 age group after a third dose,...

Pfizer, Moderna to Add Children to Trials

FDA wants more data on myocarditis

(Newser) - The availability of coronavirus vaccines for younger children could be delayed, after the Food and Drug Administration asked Pfizer and Moderna to expand its trials. The agency wants to know if a rare inflammation of the heart muscle that has surfaced in young adults would more of a problem in...

Biden Officials Planning For Possibility of Booster Shots

Administration buys 200 million doses of Pfizer vaccine

(Newser) - Experts are studying the question of whether people vaccinated against COVID will need a booster shot, and President Joe Biden’s administration is paying attention. “Requiring additional shots in the future is obviously a foreseeable potential event,” Andy Slavitt, who is on Biden’s COVID response team, said....

Vaccines for Kids Under 12 Are Still Months Away

FDA official says emergency approval could be granted by midwinter

(Newser) - Coronavirus vaccines for children under 12 are still months away, with emergency authorization for at least one vaccine expected by midwinter and full approval likely coming soon afterward, a Food and Drug Administration official says. The official tells NBC that many families are hesitant because no COVID vaccine has received...

Pfizer to Make Its Pitch for Booster Shots in US

Company meets with top health officials Monday

(Newser) - Pfizer says it plans to meet with top US health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine, per the AP . The company said it was scheduled to have the meeting with the Food and Drug Administration and other...

Pfizer Wants Approval for Third Shot

Company agrees effectiveness of its vaccine is fading as Delta variant surges

(Newser) - Seeing signs that the effectiveness of its vaccine is fading, Pfizer said Thursday it will ask for approval to distribute a third dose to help fight new coronavirus variants. The company plans to ask the Food and Drug Administration for emergency use authorization next month, CNN reports. Pfizer cited findings...

Israel Has Bad News for Pfizer Vaccine

Its efficacy drops against Delta variant, but it was still 93% effective at preventing severe disease

(Newser) - Israel's Ministry of Health says the Pfizer-BioNTech vaccine isn't offering the same level of protection against COVID-19 now that the Delta variant is dominant. In May, when the Alpha variant dominated Israel, the vaccine was found to be 95.3% effective against infection, per CNN . But in a...

Stories 41 - 60 | << Prev   Next >>
Most Read on Newser